Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China · Delayed Price · Currency is CNY 3.750
-0.050 (-1.32%)
Feb 13, 2026, 3:04 PM CST
Shenzhen Glory Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,195 | 1,445 | 1,189 | 1,267 | 1,774 | 2,244 |
Other Revenue | 3.69 | 3.69 | 3.62 | 8.27 | 16.52 | 23.75 |
| 1,199 | 1,448 | 1,193 | 1,276 | 1,790 | 2,267 | |
Revenue Growth (YoY) | -6.08% | 21.40% | -6.49% | -28.74% | -21.04% | 48.11% |
Cost of Revenue | 996.56 | 1,195 | 1,038 | 1,060 | 1,470 | 1,573 |
Gross Profit | 202.53 | 253.19 | 155 | 215.55 | 319.9 | 694.35 |
Selling, General & Admin | 142.97 | 145.27 | 153.23 | 157.94 | 170.75 | 238.12 |
Research & Development | 38.04 | 40.78 | 40.07 | 48.18 | 52.37 | 61.17 |
Other Operating Expenses | 26.01 | 22.27 | 19.96 | 18.24 | 22.4 | 18.55 |
Operating Expenses | 217.38 | 236.92 | 266.35 | 351.65 | 251.79 | 293.71 |
Operating Income | -14.85 | 16.27 | -111.34 | -136.1 | 68.11 | 400.64 |
Interest Expense | -17.93 | -5.83 | -2 | -4.44 | -7.22 | -16.98 |
Interest & Investment Income | 19.49 | 13.47 | 17.34 | 17.65 | 31.42 | 8.7 |
Currency Exchange Gain (Loss) | 11.57 | 11.57 | 4.45 | -12.26 | -1.83 | -0.1 |
Other Non Operating Income (Expenses) | -9.07 | -3.02 | -2.5 | -60.37 | -16.87 | -11.83 |
EBT Excluding Unusual Items | -10.79 | 32.46 | -94.05 | -195.53 | 73.61 | 380.42 |
Impairment of Goodwill | - | - | -10.93 | -56.2 | - | -8.06 |
Gain (Loss) on Sale of Investments | -4.43 | 1.32 | -11.98 | -113.65 | 2.29 | -10.05 |
Gain (Loss) on Sale of Assets | 0.05 | 0.12 | -0.03 | - | -0.03 | -0.01 |
Asset Writedown | -4.75 | -3.2 | -3.01 | -16.86 | -1.23 | -0.85 |
Legal Settlements | -6.32 | -6.32 | -15.25 | -11.75 | -10.74 | -8.15 |
Other Unusual Items | 8.55 | 8.55 | 7.61 | 9.61 | 10.4 | 15.18 |
Pretax Income | -17.02 | 33.6 | -127.64 | -384.37 | 74.29 | 368.47 |
Income Tax Expense | 10.32 | 7.69 | 33.18 | -56.47 | 1.03 | -1.48 |
Earnings From Continuing Operations | -27.34 | 25.91 | -160.82 | -327.9 | 73.26 | 369.95 |
Minority Interest in Earnings | -0.23 | -3.63 | 11.93 | 19.84 | -28.73 | -207.81 |
Net Income | -27.57 | 22.28 | -148.89 | -308.06 | 44.52 | 162.14 |
Net Income to Common | -27.57 | 22.28 | -148.89 | -308.06 | 44.52 | 162.14 |
Net Income Growth | - | - | - | - | -72.54% | 171.32% |
Shares Outstanding (Basic) | 842 | 844 | 845 | 845 | 831 | 798 |
Shares Outstanding (Diluted) | 842 | 884 | 845 | 845 | 870 | 837 |
Shares Change (YoY) | -13.41% | 4.64% | 0.03% | -2.86% | 3.89% | -0.97% |
EPS (Basic) | -0.03 | 0.03 | -0.18 | -0.36 | 0.05 | 0.20 |
EPS (Diluted) | -0.03 | 0.03 | -0.18 | -0.36 | 0.05 | 0.19 |
EPS Growth | - | - | - | - | -73.57% | 173.97% |
Free Cash Flow | -29.92 | 38.8 | -24.44 | 39.15 | -187.38 | 243.33 |
Free Cash Flow Per Share | -0.04 | 0.04 | -0.03 | 0.05 | -0.21 | 0.29 |
Dividend Per Share | 0.008 | 0.008 | - | - | - | - |
Gross Margin | 16.89% | 17.48% | 12.99% | 16.90% | 17.87% | 30.62% |
Operating Margin | -1.24% | 1.12% | -9.33% | -10.67% | 3.81% | 17.67% |
Profit Margin | -2.30% | 1.54% | -12.48% | -24.15% | 2.49% | 7.15% |
Free Cash Flow Margin | -2.50% | 2.68% | -2.05% | 3.07% | -10.47% | 10.73% |
EBITDA | 92.42 | 118.66 | -15.46 | -11.1 | 144.79 | 455.74 |
EBITDA Margin | 7.71% | 8.19% | -1.30% | -0.87% | 8.09% | 20.10% |
D&A For EBITDA | 107.27 | 102.39 | 95.88 | 125 | 76.68 | 55.1 |
EBIT | -14.85 | 16.27 | -111.34 | -136.1 | 68.11 | 400.64 |
EBIT Margin | -1.24% | 1.12% | -9.33% | -10.67% | 3.81% | 17.67% |
Effective Tax Rate | - | 22.89% | - | - | 1.39% | - |
Revenue as Reported | 1,199 | 1,448 | 1,193 | 1,276 | 1,790 | 2,267 |
Advertising Expenses | - | 0.75 | 1.66 | 0.37 | 0.24 | 0.47 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.